ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,832, issued on Aug. 12, was assigned to Christopher Oelkrug (Rottenburg am Neckar, Germany).
"Antibody-mediated neutralization of beta-lactamases" was invented by Christopher Roland Oelkrug (Rottenburg am Neckar, Germany) and Andreas Bernhard Joachim Schubert (Leipzig, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are antibodies, such as immunoglobulins Y (IgY) antibodies that inhibit beta-lactamase activity, e.g., TEM-1 beta-lactamase, as well as related compositions and methods of use thereof to treat infections by lactam-based antibiotic bacteria that produce beta-lactamase that can degrade antibiotics."
The patent was f...